Anticonvulsants and anxiolytics: Benzodiazepines

Anticonvulsants and anxiolytics: Benzodiazepines

nclex

nclex

NCLEX Q&A with Jannah Amiel
Extrinsic hemolytic normocytic anemia: Pathology review
Heart blocks: Pathology review
Malabsorption syndromes: Pathology review
Dyslipidemias: Pathology review
Pituitary tumors: Pathology review
Pericardial disease: Pathology review
Multiple endocrine neoplasia: Pathology review
Peripheral artery disease: Pathology review
Theoretical Foundations of Nursing
Study for Success: Habits Every Nursing Student Should Adopt
Major depressive disorder
Bipolar and related disorders
Suicide
Schizophrenia
Delirium
Cluster C personality disorders
Cluster B personality disorders
Cannabis use disorder
Cocaine use disorder
Narcolepsy (NORD)
Mood disorders: Pathology review
Personality disorders: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Eating disorders: Pathology review
Psychiatric emergencies: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Serotonin and norepinephrine reuptake inhibitors
Atypical antipsychotics
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Fat-soluble vitamin deficiency and toxicity: Pathology review
Huntington disease
Cri du chat syndrome
Marfan syndrome
Sickle cell disease (NORD)
Myocardial infarction
Peripheral artery disease
Hypertension
Tetralogy of Fallot
Heart failure
Myocarditis
Atherosclerosis and arteriosclerosis: Pathology review
Shock: Pathology review
Diabetes mellitus
Diabetic nephropathy
Diabetes insipidus and SIADH: Pathology review
Sleep apnea
Celiac disease
Crohn disease
Ulcerative colitis
Bowel obstruction
Jaundice
Neonatal hepatitis
Iron deficiency anemia
Chronic leukemia
Coagulation disorders: Pathology review
Anaphylaxis
Asthma
Candida
Osteomyelitis
Osteoarthritis
Scleroderma
Epidural hematoma
Shaken baby syndrome
Seizures and epilepsy
Frontotemporal dementia
Multiple sclerosis
Guillain-Barre syndrome
Seizures: Pathology review
Hypermagnesemia
Hypercalcemia
Hyponatremia
Chronic kidney disease
Electrolyte disturbances: Pathology review
Benign prostatic hyperplasia
Placenta previa
Placental abruption
Gestational diabetes
Gestational hypertension
Postpartum hemorrhage
Miscarriage
Sudden infant death syndrome
Acute respiratory distress syndrome
Pulmonary embolism
Pharmacokinetics: Drug elimination and clearance
Drug administration and dosing regimens
Cholinomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Class III antiarrhythmics: Potassium channel blockers
Lipid-lowering medications: Statins
Insulins
Anticoagulants: Heparin
Anticoagulants: Warfarin
Glucocorticoids
Sympathomimetics: Direct agonists
Neuromuscular blockers
Uterine stimulants and relaxants
Medication overdoses and toxicities: Pathology review
Normal heart sounds
Oxytocin and prolactin
Thyroid hormones
Insulin
Synthesis of adrenocortical hormones
Phosphate, calcium and magnesium homeostasis
Erythropoietin
Respiratory acidosis
Metabolic acidosis
Pregnancy
Breastfeeding
Pulmonary shunts
Renin-angiotensin-aldosterone system
Calcium channel blockers
Thiazide and thiazide-like diuretics
Positive inotropic medications
Lipid-lowering medications: Fibrates
Antidiuretic hormone
Hypoglycemics: Insulin secretagogues
Acid reducing medications
Pyloric stenosis
Graft-versus-host disease
Myasthenia gravis
Autoimmune hemolytic anemia
Food allergy
Vaccinations
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Febrile seizure
Brain herniation
Muscarinic antagonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Nonbenzodiazepine anticonvulsants
Opioid antagonists
Acid-base map and compensatory mechanisms
Metabolic alkalosis
Ventilation-perfusion ratios and V/Q mismatch
Emphysema
Respiratory alkalosis
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Pharmacokinetics: Drug absorption and distribution
Adrenergic antagonists: Presynaptic
Selective serotonin reuptake inhibitors
Atypical antidepressants
Cell wall synthesis inhibitors: Penicillins
Hepatitis medications
Migraine medications
Osmotic diuretics
Androgens and antiandrogens
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Puberty and Tanner staging
Carbon dioxide transport in blood

Transcript

Watch video only

Benzodiazepines are a class of medications that act as a central nervous system depressant.  They have a wide variety of uses including anxiolytic effects, or to relieve anxiety; as anticonvulsants, or to manage seizure disorders; as a hypnotic for insomnia; as an anesthetic; and to treat withdrawal syndromes. They act by enhancing the main inhibitory neurotransmitter gamma-aminobutyric acid, or GABA, by binding to its receptor.  

It’s pretty well-established that your brain’s really important. It controls your feelings, your movements, your sleep, your memory… It controls everything, whether you’re aware of it or not. The cells that make up our brain are called neurons. Neurons communicate with each other through neurotransmitters. When one neuron is stimulated, it’ll release excitatory neurotransmitters like glutamate which bind to receptors on the next neuron. This causes the next neuron to depolarize and release its own excitatory neurotransmitters, propagating the signal throughout the brain.  

Now, we also have inhibitory neurons that will shut down this chain of events. These neurons release the main inhibitory neurotransmitter gamma-aminobutyric acid, or GABA, which binds to GABA receptors on other neurons. These receptors are large, multi unit complexes that form ligand-gated ion channels that open up to let Cl- ions into the cell. The influx of negatively charged ions causes hyperpolarization, where the cell’s membrane potential becomes more negative, which means it’s much more difficult for it to depolarize and fire off an action potential, meaning it’s less responsive to stimuli.  

Alright, now there are cases where neurons in the brain start sending out more excitatory signals than normal. This can occur due to either too much excitation by the excitatory neurotransmitters, or too little inhibition by the inhibitory neurotransmitters like GABA. Excessive excitatory signals can cause psychiatric disorders like anxiety, and neurological disorders like seizures and epilepsy.  

Okay, so one way we can decrease the excitatory signals is by enhancing the effect of inhibitory neurons through medication like benzodiazepines. They are composed of a benzene ring that consists of six carbon atoms fused to a diazepine ring that is made up of 5 carbon atoms and two nitrogen atoms.    
Now, based on the overall duration of action, these medications can be subdivided into short-acting benzodiazepines, like ALPRAZolam, Triazolam, Oxazepam, and Midazolam; intermediate-acting benzodiazepines, such as Temazepam, LORazepam, and ClonazePAM; and finally, long-acting benzodiazepines, like ChlordiazePOXIDE, DiazePAM, and Flurazepam. So, to remember short-acting benzodiazepines think of “ATOM”; for intermediate-acting, remember that these medications are tender, loving, and caring, or short TLC; and finally for long-acting benzodiazepines, think of alphabet and it’s order CDeF. These medications target the BZ site of GABAA receptors, which is located between ⍺1 and 2 subunits of the receptor. When both benzodiazepine and GABA bind to their separate sites on the receptor, benzodiazepines increase the frequency of Cl- channels opening, thereby increasing the influx of Cl- ions. As a result, high intracellular concentrations of Cl- ions cause membrane hyperpolarization, which means it’s much more difficult for neuron to depolarize and fire off an action potential. Now, a similar group of medications called barbiturates also function by binding to GABAA receptors. The important distinction is that barbiturates work by increasing the duration of Cl- channels opening and unlike benzodiazepines, they can cause the channels to open even in the absence of GABA.

Now, let’s draw a chart of the dose-dependent effects of benzodiazepines. On the left side of the chart, let’s place central nervous effects and on the bottom, let’s place dose. Low doses of benzodiazepines cause sedation, disinhibition, and anxiolysis; but as the dose increases, benzodiazepines cause hypnosis and anesthesia. Since they don’t have GABA mimetic effect, benzodiazepines reach the plateau; therefore they are not associated with medullary depression and coma.  

Alright, so benzodiazepines are indicated when the neurons get “super excited” and we want to calm them down like in anxiety disorders, or during a panic attack. It’s important to note that preferred medications for the long-term treatment of panic attacks are selective serotonin reuptake inhibitors, or short SSRIs, due to abuse potential, dependence, and tolerance of benzodiazepines. Benzodiazepines are also very effective anticonvulsants and are considered the treatment of choice for status epilepticus, which is when a person has over 5 minutes of ongoing seizures or multiple seizures without returning to normal in between. Certain benzodiazepines are also used for anesthesia since we basically want to depress the function of the patient’s nervous system. For the same reason, they are an effective treatment for insomnia, but they decrease REM sleep. Moreover, because they decrease REM sleep, they can also be used to treat night terrors, which is a sleep disorder similar to nightmares but far more dramatic as it’s associated with screaming and crying. Since alcohol and barbiturates also work by targeting GABAA receptors, benzodiazepines can be used to manage their withdrawal symptoms by decreasing their severity. DiazePAM can also be used as the second-line treatment for eclampsia, which is a life-threatening complication of pregnancy that is associated with seizures. But, it’s important to note that diazePAM should be used only if seizures recur after giving magnesium sulfate (MgSO4), which is the first-line treatment for eclampsia. Finally, they are sometimes used as muscle relaxants to treat spasms, like those caused by cerebral palsy

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra" Psychiatry and Clinical Neurosciences (2003)
  5. "Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam" Clin Pharmacol Ther (1986)
  6. "Short acting benzodiazepines" BMJ (1993)
  7. "Treatment of Benzodiazepine Dependence" N Engl J Med (2017)